One of the greatest mysteries of our planet is how a soup of lifeless chemicals transformed into the first living cell. There are several competing theories about where this happened, from frozen ...
Another factor related to their length is that they tend to form very complex structures, with many different areas of the ...
Pharmaceutical Technology on MSN
Takeda and Iambic announce $1.7bn deal to advance small molecule programmes
The partnership aims to advance high-priority small molecule programmes using Iambic’s AI models and wet lab capabilities.
Researchers at the MRC Laboratory of Molecular Biology in Cambridge have discovered a ribozyme that is shockingly small, yet capable of the fundamental steps of self-replication. They call it QT45 — ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the ...
UVA scientists discovered a molecule that blocks a key gene that drives glioblastoma, offering hope for a new treatment ...
UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, ...
COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...
As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...
Preclinical results indicate new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results